Furthermore, loss of IGF2BP3 obviously induces ferroptosis in HCC cells by decreasing NRF2 mRNA stability in an m6A-dependent manner after sorafenib treatment (Lu et al., 2022). This evidence concerns the gene IGF2BP3 and hepatocellular carcinoma.